🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of members share comparison images, injection guides and claims of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users administering products of uncertain source.

Several experts stated the demand for retatrutide could be connected to the rising cost of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Platform Response and Content Removal

According to TikTok, the service has taken down violative material and banned related keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Digital Trading Activities

Research also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, filled with images of slimming results, glowing testimonials and detailed guides for preparing or administering at home.

Within moments of joining one community, a vendor shared contact information, where most transactions occur. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Information and Pricing

Within these groups, messages show dark colored packages with postal service stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When asked how long a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram stated it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her team has already seen patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject patients to potentially serious health risks”.